Quest Diagnostics Incorporated [DGX] is following upward trend in the market concluded with the last trading session. The shares of the Healthcare sector company has a current value of $104.75 after DGX shares went up by 1.25% during the last trading session. One of the reasons why Healthcare stocks may go bullish is increased momentum in the press.
Quest Diagnostics Incorporated [NYSE:DGX]: Analyst Rating and Earnings
Its stock price has been found in the range of 78.95 to 107.97. This is compared to its latest closing price of $103.46.
Keep looking out for the next-scheduled quarterly financial results that this company is expected to put out, which is slated to occur on Tue 22 Oct (In 16 Days).
Fundamental Analysis of Quest Diagnostics Incorporated [DGX]
Now let’s turn to look at profitability: with a current Operating Margin for Quest Diagnostics Incorporated [DGX] sitting at +16.25 and its Gross Margin at +34.30, this company’s Net Margin is now 9.60%. These metrics indicate that this company is not generating as much profit, after accounting for expenses, compared to its market peers.
This company’s Return on Total Capital is 13.43, and its Return on Invested Capital has reached 9.80%. Its Return on Equity is 14.46, and its Return on Assets is 6.82. These metrics show a mixed bag, which means that this investment’s attractiveness can be quickly increased or decreased in the short term, depending on future updates DGX financial performance.
Turning to investigate this organization’s capital structure, Quest Diagnostics Incorporated [DGX] has generated a Total Debt to Total Equity ratio of 76.51. Similarly, its Total Debt to Total Capital is 43.35, while its Total Debt to Total Assets stands at 36.27. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is 7.24, and its Long-Term Debt to Total Capital is 65.74.
What about valuation? This company’s Enterprise Value to EBITDA is 11.72 and its Total Debt to EBITDA Value is 2.60. The Enterprise Value to Sales for this firm is now 2.37, and its Total Debt to Enterprise Value stands at 0.26. Quest Diagnostics Incorporated [DGX] has a Price to Book Ratio of 2.16, a Price to Cash Flow Ratio of 9.65 and P/E Ratio of 19.73. These metrics all suggest that Quest Diagnostics Incorporated is more likely to generate a positive ROI.
Shifting the focus to workforce efficiency, Quest Diagnostics Incorporated [DGX] earns $163,717 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 7.74 and its Total Asset Turnover is 0.70. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 0.87 and its Current Ratio is 0.94. This company is not investing its short-term assets in an optimally efficient way, making it a riskier investment.
Quest Diagnostics Incorporated [DGX] has 135.00M shares outstanding, amounting to a total market cap of $14.14B. Its stock price has been found in the range of 78.95 to 107.97. At its current price, it has moved down by -2.98% from its 52-week high, and it has moved up 32.68% from its 52-week low.
This stock’s Beta value is currently 0.85, which indicates that it is 1.64% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 50.71. This RSI score is good, suggesting this stock is neither overbought or oversold.
Conclusion: Is Quest Diagnostics Incorporated [DGX] a Reliable Buy?
Shares of Quest Diagnostics Incorporated [DGX], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.